Complete regression of retinoblastoma following intra-arterial chemotherapy.

Publication/Presentation Date

6-7-2011

Abstract

A 22-month-old girl with Group C unilateral retinoblastoma demonstrated dramatic tumor regression after two infusions of 5 mg of intra-arterial melphalan as primary therapy. Complete tumor control without recurrence was noted at 1 year. Retinal and choroidal perfusion was intact and the electroretinogram improved following therapy.

Volume

48 Online

First Page

23

Last Page

25

ISSN

1938-2405

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

21634361

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS